FDA
Albuterol, fentanyl and naloxone injectable are among the drugs being recalled – many of which are in very short supply, with no alternate source available
By leveraging naloxone and buprenorphine, along with behavioral therapies, medication-assisted treatment attacks opioid addiction from all sides
An EF3 tornado damaged the Pfizer factory responsible for producing nearly 25% of the company’s sterile injectable medicines
Senate Bill 186 allows the use of Opvee as overdoses in the state are rising
Studies, funded by the federal government, found Opvee achieved similar recovery results to Narcan
FDA Commissioner Dr. Robert Califf cited “the dire public health need” for the opioid antagonist
The overdose treatment could be more widely available in spring
The hope is that the bivalent shots will thwart another winter surge
Robert Califf layed out a framework for combating drug addiction and overdoses
The CDC will issue its recommendation on vaccine administration after an upcoming vote
The CDC will decide whether to formally recommend the booster for this age group
Paxlovid is a faster, cheaper treatment than other authorized drugs, but initial supplies will be extremely limited
The treatment has been shown to significantly lower the rates of hospitalizations and deaths among people with coronavirus infections
The push comes amid concern about increased spread of the virus from holiday travel and gatherings
